PRA Stock Recent News
PRA LATEST HEADLINES
ProAssurance (PRA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ProAssurance (PRA) reported earnings 30 days ago. What's next for the stock?
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ProAssurance Corporation (NYSE: PRA) to The Doctors Company. Under the terms of the proposed transaction, shareholders of ProAssurance will receive $25.00 in cash for each share of ProAssurance that they own. KSF is seeking to determine whether this consideration and the process that led to it are a.
Does ProAssurance (PRA) have what it takes to be a top stock pick for momentum investors? Let's find out.
ProAssurance (PRA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
PRA shareholders will receive $25 per share in cash from the $1.3 billion acquisition by The Doctors Company.
MONSEY, N.Y., March 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of ProAssurance Corporation (NYSE: PRA) (“ProAssurance”) to The Doctors Companies (“TDC”) for $25.00 per share in cash.
MILWAUKEE , March 19, 2025 /PRNewswire/ -- The Ademi Firm is investigating ProAssurance (NYSE: PRA) for possible breaches of fiduciary duty and other violations of law in its transaction with The Doctors Company. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.
NEW YORK , March 19, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating ProAssurance Corporation (NYSE: PRA ), relating to the proposed merger with The Doctors Company.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of ProAssurance Corporation (NYSE: PRA) to The Doctors Company for $25.00 in cash per share is fair to ProAssurance shareholders. Halper Sadeh encourages ProAssurance shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whethe.